Eden Research (LON:EDEN) Shares Up 13.4% – What’s Next?

Eden Research plc (LON:EDEN)’s stock price shot up 13.4% during mid-day trading on Wednesday . The stock traded as high as GBX 3.80 ($0.05) and last traded at GBX 3.80 ($0.05). 610,189 shares changed hands during trading, a decline of 9% from the average session volume of 670,084 shares. The stock had previously closed at GBX 3.35 ($0.04).

Eden Research Stock Performance

The firm has a fifty day simple moving average of GBX 2.79 and a 200-day simple moving average of GBX 3.43. The stock has a market cap of £20.27 million, a price-to-earnings ratio of -13.31 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26.

Eden Research (LON:EDEN) last issued its earnings results on Tuesday, May 6th. The company reported GBX (0.36) ($0.00) EPS for the quarter. Eden Research had a negative net margin of 38.70% and a negative return on equity of 11.63%. Analysts forecast that Eden Research plc will post -66.0000038 EPS for the current fiscal year.

Insider Buying and Selling at Eden Research

In other Eden Research news, insider Sean M. Smith acquired 426,986 shares of the company’s stock in a transaction that occurred on Tuesday, April 1st. The shares were acquired at an average price of GBX 234 ($3.11) per share, with a total value of £999,147.24 ($1,329,714.19). Also, insider Alexander John Abrey bought 167,947 shares of the firm’s stock in a transaction on Tuesday, March 4th. The stock was acquired at an average cost of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,705.36). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.